Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care

Cardiovascular disease (CVD) complicates type 2 diabetes. Empagliflozin and liraglutide have demonstrated improved survival in patients with type 2 diabetes and established CVD. We assessed prevalence and standard of care of patients with type 2 diabetes and established CVD managed in primary care....

Descripción completa

Detalles Bibliográficos
Autores principales: Rungby, Jorgen, Schou, Morten, Warrer, Per, Ytte, Lars, Andersen, Gert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704655/
https://www.ncbi.nlm.nih.gov/pubmed/29276653
http://dx.doi.org/10.1097/XCE.0000000000000135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704655/
https://www.ncbi.nlm.nih.gov/pubmed/29276653
http://dx.doi.org/10.1097/XCE.0000000000000135

Ejemplares similares